GLP-1 Coverage Is COLLAPSING in 2027
GLP-1 access is getting tighter just as obesity treatment is becoming more effective, more affordable, and more important to public health.In this episode of the On The Pen Podcast, Dave Knapp breaks ...
26 Elo 34min
$50 Zepbound Incoming? China Has US in a GLP-1 “Chokehold”
Could GLP-1 medications eventually cost just $40 to $50 per month? Hims & Hers CEO Andrew Dudum thinks so, and if he’s right, it could completely change access to obesity treatment in America.But gett...
18 Elo 45min
200 GLP-1 Deaths, Chrissy Metz & a Stunning Harvard Study
Https://www.otplinks.comBased on the transcript flow, here’s a clean YouTube description with chapter timestamps. The transcript itself doesn’t include timecodes, so these are estimated from speaking ...
12 Elo 31min
Novo Nordisk Warned us For Years About Synthesized Semaglutide. Now They Want In.
Novo Nordisk has spent years warning patients, regulators, lawmakers, and courts about the risks of synthetic semaglutide. Now, as patents begin to expire and China’s pharmaceutical industry becomes i...
4 Elo 18min
Retatrutide Biologic Battle: The Story Gets Bigger
https://www.otplinks.comhttps://www.voafit.com/otpEpisode Referenced: https://www.youtube.com/watch?v=K8kaSoFCZ0c&t=41sThe retatrutide biologic fight is bigger than folks understand.This breakdown cov...
28 Heinä 20min
GLP-1 Showdown: Inside The High Stakes War over Patients
Novo Nordisk just declared legal war on Eli Lilly as the battle over GLP-1 patients intensifies. But just because patients are being fought over does not mean they are being fought for.In this episode...
22 Heinä 27min
Medicare, New Drugs, and a Surprising GLP-1 Trend, What Patients Need to Know
What happens when patients stop taking a GLP-1? New real-world data reveals that more than half eventually come back, and it may completely change the way we think about obesity treatment.In this week...
14 Heinä 31min
